PLURISTEM THERAPEUTICS INC 4
4 · PLURISTEM THERAPEUTICS INC · Filed Feb 17, 2016
Insider Transaction Report
Form 4
Aberman Zami
DirectorCEO & Co. Chairman
Transactions
- Purchase
Common Stock
2016-02-16$1.07/sh+9,000$9,630→ 100,400 total(indirect: By Rose Hitech Ltd.) - Purchase
Common Stock
2016-02-16$1.06/sh+6,000$6,360→ 106,400 total(indirect: By Rose Hitech Ltd.)
Holdings
- 2,118,298
Common Stock